In addition, PF not only ameliorates atherosclerosis by inhibiting TLR4-mediated NF-κB activation (11) but also inhibits OX-LDL-induced apoptosis and inflammation in human coronary artery endothelial cells by regulating the Wnt/β-catenin pathway (12). The gene discussed is NFKB1; the disease is atherosclerosis.